Grant RDF
pages:- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- more...
- 4-H Youth Development Program/Spa# 99047-C Timpooche
- 4-Phenyl Butyrate Mediated Secretion Rescue in Alpha 1-Anti Trysin Deficient Individuals
- 43Rd Aiaa Joint Propulsion Conference Student Design Challenge - University of Florida - Agent Orange
- 48-Mo Mlt-Center Randomized Dbl-Mskd Plcb-Cntrl Clinical Study to Evaluation the Effectiveness & SAF of Oral Memantine in Daily Doses
- 48-Wk Multi-Center Randomized 2-Blnd Prl-Grp Evaluation of Comp Eff/SAF/Tolof Exelon 10 and 15 Cm2 Patch in Pt C Alzheimer S Disease...
- 5 R01 AG025079-03
- 5 R01 CA039742-24
- 5 R01 CA098974-03
- 5-Alpha Reductase and Anabolic Effects of Testosterone
- 5-Alpha Reductase and Anabolic Effects of Testosterone
- 5-Alpha Reductase and Anabolic Effects of Testosterone
- 5-Alpha Reductase and Anabolic Effects of Testosterone
- 5/5-Randomized Trial of Parent Training for Young Children With Autism
- 500-01-0043
- 5R01-CA118105-02
- 5R42DK068913-03 "Development of ACTH antagonists"
- 5Th International Meeting of Gene and Cell Therapies for Arthritis and Related Disorders
- 6-Month, ...Study of the SAF/Eff of Myfortic (Erl080) With Simulect, Corticosteroids & 2 Diff Lvls of Tacrolimus...
- 6002-Int-001..Safety Study with Oral 20 or 40 Mg Doses of Kw-6002 (Istratdefylline) As Treatment...
- 6Th Annual University of Florida Movement Disorders Symposium
- 6Th Annual University of Florida Movement Disorders Symposium
- 6wk Rndmzd Dbl-Bld Dbl-Dmmy Plcb-Ctrl Mlti-Ctr Stdy to Asseseffct of Tegaseroc 2md Tid and 6mg Tid on Dyspeptic Smptms...
- 75012
- 75012
- 75012
- 7Th International Conference on Usstable Microsatellites in Human Disease
- 8Th Flight Competition Review
- 8Th International Primary Hyperoxaluria Workshop
- 9-Month Multi-Ctr Dbl-Bld Plcb-Cntrld Clin Trl Evalu Effct Doxycycline Monohydrate Modifd Relse Capsls Qd Depth ....
- 9238Il/0048:...Fulvestrant Vs. Exemestane in Postmenopausal Women With...Breas Cancer..Ai Therapy